KROS
Price
$15.80
Change
+$0.05 (+0.32%)
Updated
Sep 25 closing price
Capitalization
641.72M
34 days until earnings call
RAPT
Price
$24.43
Change
-$0.02 (-0.08%)
Updated
Sep 26, 11:44 AM (EDT)
Capitalization
404.35M
Interact to see
Advertisement

KROS vs RAPT

Header iconKROS vs RAPT Comparison
Open Charts KROS vs RAPTBanner chart's image
Keros Therapeutics
Price$15.80
Change+$0.05 (+0.32%)
Volume$220.26K
Capitalization641.72M
RAPT Therapeutics
Price$24.43
Change-$0.02 (-0.08%)
Volume$200
Capitalization404.35M
KROS vs RAPT Comparison Chart in %
Loading...
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KROS vs. RAPT commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KROS is a Buy and RAPT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (KROS: $15.80 vs. RAPT: $24.45)
Brand notoriety: KROS and RAPT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KROS: 54% vs. RAPT: 144%
Market capitalization -- KROS: $641.72M vs. RAPT: $404.35M
KROS [@Biotechnology] is valued at $641.72M. RAPT’s [@Biotechnology] market capitalization is $404.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KROS’s FA Score shows that 1 FA rating(s) are green whileRAPT’s FA Score has 0 green FA rating(s).

  • KROS’s FA Score: 1 green, 4 red.
  • RAPT’s FA Score: 0 green, 5 red.
According to our system of comparison, KROS is a better buy in the long-term than RAPT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KROS’s TA Score shows that 4 TA indicator(s) are bullish while RAPT’s TA Score has 4 bullish TA indicator(s).

  • KROS’s TA Score: 4 bullish, 5 bearish.
  • RAPT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RAPT is a better buy in the short-term than KROS.

Price Growth

KROS (@Biotechnology) experienced а -1.50% price change this week, while RAPT (@Biotechnology) price change was +19.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

KROS is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KROS($642M) has a higher market cap than RAPT($404M). RAPT YTD gains are higher at: 93.434 vs. KROS (-0.190). KROS has higher annual earnings (EBITDA): 25.5M vs. RAPT (-111.99M). KROS has more cash in the bank: 690M vs. RAPT (169M). RAPT has less debt than KROS: RAPT (3.16M) vs KROS (18M). KROS has higher revenues than RAPT: KROS (233M) vs RAPT (0).
KROSRAPTKROS / RAPT
Capitalization642M404M159%
EBITDA25.5M-111.99M-23%
Gain YTD-0.19093.434-0%
P/E Ratio49.38N/A-
Revenue233M0-
Total Cash690M169M408%
Total Debt18M3.16M569%
FUNDAMENTALS RATINGS
RAPT: Fundamental Ratings
RAPT
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KROSRAPT
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
80%
Bearish Trend 29 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
KROS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACGCX39.21N/A
N/A
American Century Discplnd Cor Val C
PMYCX45.33N/A
N/A
Putnam Core Equity Fund C
HFCGX32.67N/A
N/A
Hennessy Cornerstone Growth Investor
MELIX16.76N/A
N/A
Morgan Stanley Inst EMkts Ldrs I
MXJVX10.51N/A
N/A
Empower International Value Instl

KROS and

Correlation & Price change

A.I.dvisor indicates that over the last year, KROS has been loosely correlated with INO. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if KROS jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KROS
1D Price
Change %
KROS100%
+0.32%
INO - KROS
53%
Loosely correlated
-3.57%
AXON - KROS
43%
Loosely correlated
+2.02%
RAPT - KROS
39%
Loosely correlated
+2.09%
DNLI - KROS
39%
Loosely correlated
-0.37%
ALT - KROS
39%
Loosely correlated
N/A
More